References
- S. Sathigari, G. Chadha, Y-H. Lee, N. Wright, D. Parsons, V. Rathnagiri, O. Fasina and R. Babu, Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes, AAPS Pharm-SciTech. 10 (2009) 81-87; DOI: 10.1208/S12249-008-9180-3.
- K. Kesavan, V. U. Rao, K. Bindu, P. S. Rajinikanth, J. K. Pandit and J. Balasubramaniam, Immediate release tablets of valsartan and efavirenz: Role of concentration of superdisintegrant, Ars. Pharm. 49 (2008) 229-243.
- W. T. Makooi-Morehead, J. D. Buehlar and B. R. Landmann, Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants, US Pat. 6,238,695 B1, 29 May 2001; http://www.freepatentsonline.com/65551333.html/
- N. Zhao and L. L. Augsburger, The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressible tablets, AAPS PharmSciTech. 6 (2005) E120-126.
- Food and Drug Administration Department, Efavirenz http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm?PrintAll=1
- J. Balasubramaniam, K. Bindu, V. U. Rao, D. Ray, R. Haldar and A. W. Brzeczko, Effect of superdisintegrants on dissolution of cationic drugs, Dissol. Technol. 15 (2008) 18-25.
- M. S. Gordon, V. S. Rudraraju, K. Dani and Z. T. Chowhan, Effect of the mode of superdisintegrants incorporation on dissolution in wet granulated tablets, J. Pharm. Sci. 82 (1993) 220-226.
- B. Preetha, J. K. Pandit, V. U. Rao, K. Bindu, Y. V. Rajesh and J. Balasubramaniam, Comparative evaluation of mode of incorporation of superdisintegrants on dissolution of model drugs from wet granulated tablets, Acta Pharm. Sci. 50 (2008) 229-236.
- Y. S. Yen, C. R. Chen, M. T. Lee and L. C. Chen, Investigation of dissolution enhancement of nifedipine by deposition on superdisintegrants, Drug. Dev. Ind. Pharm. 23 (1997) 313-317; DOI: 10.3109/03639049709149809.
- J. Kukura, J. L. Baxter and F. J. Muzzio, Shear distribution and variability in the USP apparatus 2 under turbulent conditions, Int. J. Pharm. 279 (2004) 9-17; DOI: 10.1016/j.ijpharm.2004.03.033.
- L. G. McCarthy, C. Kosiol, A. M. Healy, G. Bradley, J. C. Sexton and O. I. Corrigan, Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus, AAPS Pharm. Sci.Tech. 4 (2005) 1-16.
- S. A. Qureshi and J. Shabnam, Cause of high variability in drug dissolution testing and its impact on setting tolerances, Eur. J. Pharm. Sci. 12 (2001) 271-276; DOI: 10.1016/S0928-0987(00)00174-3.
- S. A. Qureshi, Developing discriminatory drug dissolution tests and profiles: Some thoughts for consideration on the concept and its interpretation, Dissol. Technol. 13 (2006) 18-23.
- M. S. Kim, S. J. Jin, J. S. Kim, H. J. Park, H. S. Song, R. H. H. Neubert and S. J. Hwang, Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm. 69 (2008) 454-465; DOI: 10.1016/j.ejpb.2008.01.007.